Cadrenal Therapeutics, Inc. research brief
CIK 1937993
Generated Nov. 17, 2026, 10:35 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: PONTE VEDRA Florida. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- July 15, 2026 · D · 0001213900-26-078373 · Source evidence
Reported offering amount: 8843849 USD. Reported amount sold: 8843849 USD.
- April 6, 2026 · D · 0001213900-26-040457 · Source evidence
Reported offering amount: 7923235 USD. Reported amount sold: 7923235 USD.
- Dec. 31, 2025 · D · 0001213900-25-127129 · Source evidence
Reported offering amount: 4396329 USD. Reported amount sold: 4396329 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Cadrenal Therapeutics, Inc. research brief,” CIK 1937993, retrieved Nov. 17, 2026, 10:35 p.m.. Cite the specific accessions used. No amounts have been summed.